21 CFR 173.110
§ 173.110 Amyloglucosidase derived from
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 173.110, § 173.110 Amyloglucosidase derived from, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/85106
- Permanent ID
ys:prov:85106@1- SHA-256
bfef14e4e8908829ac56bcd47a33048798d666147f5c0606bfac3bbe5af8464d
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Amyloglucosidase enzyme product, consisting of enzyme derived from Rhizopus niveus, and diatomaceous silica as a carrier, may be safely used in food in accordance with the following conditions:
(a) Rhizopus niveus is classified as follows: Class, Phycomycetes; order, Mucorales; family, Mucoraceae; genus, Rhizopus; species, niveus.
(b) The strain of Rhizopus niveus is nonpathogenic and nontoxic in man or other animals.
(c) The enzyme is produced by a process which completely removes the organism Rhizopus niveus from the amyloglucosidase.
(d) The additive is used or intended for use for degrading gelatinized starch into constituent sugars, in the production of distilled spirits and vinegar.
(e) The additive is used at a level not to exceed 0.1 percent by weight of the gelatinized starch.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.